Susan Gail Kreissman | Scholars@Duke

Susan Gail Kreissman
Professor of Pediatrics

The emphasis of Dr Kreissman's clinical research involves the study of childhood neuroblastoma. Neuroblastoma is the most common extracranial solid tumor of childhood and this disease has a diverse clinical phenotype and prognosis. Dr Kreissman has developed, written, and served as national protocol chairman for 2 clinical trials designed to improve outcome for children with the high risk form of this disease through the Children's Oncology Group (COG). Results of this protocol have been published " A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma" and established the new standard of using unpurged PBSC to support autologous transplant in high risk neuroblastoma. Dr. Kreissman also serves as a member of the Neuroblastoma committees for COG and is PI for COG studies at Duke. She is involved in designing and implimenting additional new protocols for the treatment of neuroblastoma.

Current Appointments & Affiliations

Professor of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2009
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2000

Contact Information

393 Hanes House, Durham, NC 27710
Box 102382 DUMC, Durham, NC 27710
kreis001@mc.duke.edu (919) 684-3401

Background
Education, Training, & Certifications
- Research Fellow, Pediatric Hematology/Oncology, Pediatrics, Children's Hospital Boston 1989 - 1991
- Clinical Fellow, Pediatric Hematology/Oncology, Pediatrics, Children's Hospital Boston 1988 - 1989
- Resident, Pediatrics, Children's Hospital Boston 1986 - 1988
- Intern, Pediatrics, Children's Hospital Boston 1985 - 1986
- M.D., Mount Sinai School of Medicine 1985
Duke Appointment History
- Associate Professor of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2006 - 2009
- Associate Clinical Professor of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2001 - 2006
- Instructor, Temporary in the Department of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2000 - 2001
Research
Selected Grants
- COG Work Order: AALL1131: Ph III Clofarabine in High Risk B ALL awarded by Children's Hospital of Philadelphia 2015 - 2020
- NCI Community Oncology Research Program (NCORP) Research Base Grant awarded by Children's Hospital of Philadelphia 2014 - 2019
- COG WORK ORDER: BIQSFP AALL1131 awarded by Children's Hospital of Philadelphia 2016 - 2019
- COG WORK ORDER: (PROJECT: EVERYCHILD (APEC14B1) PCR - COG FOUNDATION awarded by Children's Hospital of Philadelphia 2015 - 2019
- Per Case Reimbursement : NIH National Clinical Trials Network (NCTN) awarded by Children's Hospital of Philadelphia 2014 - 2019
- Workload Intensity NIH National Clinical Trials Network (NCTN) awarded by Children's Hospital of Philadelphia 2014 - 2019
- COG Work Order AAML: 1031--Millennium Pharmaceuticals, Inc. awarded by Children's Hospital of Philadelphia 2013 - 2018
- PBTC-043 awarded by St. Jude Children's Research Hospital 2015 - 2017
- Pediatric Brain Tumor Consortium awarded by St. Jude Children's Research Hospital 2014 - 2017
- Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma awarded by Alex's Lemonade Stand 2013 - 2015
- COG Work Order AALL07P1--Millennium Pharmaceuticals, Inc. awarded by Children's Hospital of Philadelphia 2013 - 2015
Publications & Artistic Works
Selected Publications
- Conference Papers
  - Fangusaro, J, Onar-Thomas, A, Poussaint, TY, Wu, S, Ligon, AH, Lindeman, N, Banerjee, A, Packer, RJ, Kilburn, LB, Pollack, IF, Jakacki, RI, Qaddoumi, I, Fisher, PG, Dhall, G, Baxter, P, Kreissman, SG, Stewart, CF, Pfister, SM, Jones, DTW, Vezina, G, Stern, J, Panigrahy, A, Jones, BV, Patay, Z, Tamrazi, B, Jones, JY, Haque, SS, Enterline, DS, Cha, S, Doyle, LA, Smith, M, Boyett, JM, Dunkel, IJ, and Fouladi, M. "A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY." June 2017. Link to Item
  - Poetschger, U, Naranjo, A, Yanik, G, Castellani, MR, Lambert, B, Lewington, V, Bar-Server, Z, Oudoux, A, Kaminska, A, Taborska, K, Biassoni, L, Parisi, MT, Shulkin, BL, Nadel, HR, Gelfand, M, Park, J, Kreissman, SG, Valteau-Couanet, D, Matthay, KK, and Ladenstein, R. "The Way Towards an International MIBG Skeletal Score for High Risk Neuroblastoma: The Statistical Perspective." November 2016. Link to Item
  - DuBois, SG, Mody, R, Van Ryn, C, Naranjo, A, Kreissman, SG, Baker, D, Parisi, MT, Shulkin, BL, Maris, JM, Batra, V, Park, JR, Matthay, KK, and Yanik, GA. "Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children's Oncology Group (COG)." May 20, 2016. Full Text Link to Item
  - DuBois, SG, Temple, W, Mendelsohn, L, Kim, GE, Nekritz, E, Gustafson, C, Lin, L, Giacomini, K, Naranjo, A, Van Ryn, C, Yanik, GA, Kreissman, SG, Hogarty, MD, and Matthay, KK. "Vesicular monoamine transporter protein expression in neuroblastoma: A report from the Children's Oncology Group." May 20, 2015. Link to Item
  - Yanik, G, Naranjo, A, Parisi, MT, Shulkin, BL, Nadel, H, Gelfand, MJ, Ladenstein, R, Boubaker, A, Poetschger, U, Valteau-Couanet, D, Kreissman, SG, Park, JR, and Matthay, KK. "Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma." February 2015. Full Text
  - Boubaker, A, Poetschger, U, Lambert, B, Castellani, MR, Bar-Sever, Z, Oudoux, A, Kaminska, A, Taborska, K, Kreissman, SG, Yanik, G, Matthay, KK, Naranjo, A, Park, JR, Valteau-Couanet, D, and Ladenstein, R. "Validation of the mIBG SIOPEN Scoring Method in 2 independent High Risk Neuroblastoma Trial Populations." October 2014. Link to Item
  - Haas-Kogan, D, Douglas, J, London, W, McCauley Van Ryn, C, von Allmen, D, Davidoff, A, Villablanca, J, Matthay, K, DuBois, S, Kreissman, S, La Quaglia, M, and Park, J. "Extent of Lymph Node Radiation Coverage in High-Risk Neuroblastoma Does Not Affect Clinical Outcome: A Report From the COG A3973 Study." September 2014. Full Text
  - Boubaker, A, Poetschger, U, Lambert, B, Castellani, MR, Bar-Server, Z, Oudoux, A, Kaminska, A, Taborska, K, Biassoni, L, Kreissman, SG, Yanik, GA, Narajo, A, Parisi, MT, Shulkin, BL, Matthay, KK, Park, JR, Valteau-Couanet, D, and Ladenstein, RL. "Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials." May 20, 2014. Link to Item
  - Yanik, GA, Naranjo, A, Parisi, MT, Shulkin, BL, Nadel, HR, Gelfand, MJ, Ladenstein, RL, Boubaker, A, Poetschger, U, Lambert, B, Castellani, MR, Valteau-Couanet, D, Kreissman, SG, Park, JR, and Matthay, KK. "Validation of postinduction Curie scores in high-risk neuroblastoma." May 20, 2014. Link to Item
- Journal Articles
  - Yanik, GA, Parisi, MT, Naranjo, A, Nadel, H, Gelfand, MJ, Park, JR, Ladenstein, RL, Poetschger, U, Boubaker, A, Valteau-Couanet, D, Lambert, B, Castellani, M-R, Bar-Sever, Z, Oudoux, A, Kaminska, A, Kreissman, SG, Shulkin, BL, and Matthay, KK. "Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1." Journal of nuclear medicine : official publication, Society of Nuclear Medicine 59, no. 3 (March 2018): 502-508. Full Text
  - Ladenstein, R, Lambert, B, Pötschger, U, Castellani, M-R, Lewington, V, Bar-Sever, Z, Oudoux, A, Śliwińska, A, Taborska, K, Biassoni, L, Yanik, GA, Naranjo, A, Parisi, MT, Shulkin, BL, Nadel, H, Gelfand, MJ, Matthay, KK, Park, JR, Kreissman, SG, Valteau-Couanet, D, and Boubaker, A. "Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials." European journal of nuclear medicine and molecular imaging 45, no. 2 (February 2018): 292-305. Full Text
  - DuBois, SG, Mody, R, Naranjo, A, Van Ryn, C, Russ, D, Oldridge, D, Kreissman, S, Baker, DL, Parisi, M, Shulkin, BL, Bai, H, Diskin, SJ, Batra, V, Maris, JM, Park, JR, Matthay, KK, and Yanik, G. "MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group." Pediatric blood & cancer 64, no. 11 (November 2017). Full Text
  - La Quaglia, MP, Haas-Kogan, D, Park, J, Kreissman, SG, von Allmen, D, Davidoff, A, London, WB, and Khanna, G. "Reply to J. Stenman et al." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35, no. 17 (June 2017): 1966-1967. Full Text
  - von Allmen, D, Davidoff, AM, London, WB, Van Ryn, C, Haas-Kogan, DA, Kreissman, SG, Khanna, G, Rosen, N, Park, JR, and La Quaglia, MP. "Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35, no. 2 (January 2017): 208-216. Full Text
  - Temple, W, Mendelsohn, L, Kim, GE, Nekritz, E, Gustafson, WC, Lin, L, Giacomini, K, Naranjo, A, Van Ryn, C, Parisi, MT, Shulkin, BL, Yanik, GA, Kreissman, SG, Hogarty, M, Matthay, KK, and DuBois, SG. "Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group." European journal of nuclear medicine and molecular imaging (April 5, 2016). Full Text
  - Temple, W, Mendelsohn, L, Kim, GE, Nekritz, E, Gustafson, WC, Lin, L, Giacomini, K, Naranjo, A, Van Ryn, C, Yanik, GA, Kreissman, SG, Hogarty, M, Matthay, KK, and DuBois, SG. "Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group." European journal of nuclear medicine and molecular imaging 43, no. 3 (March 2016): 474-481. Full Text
  - Englum, BR, Rialon, KL, Speicher, PJ, Gulack, B, Driscoll, TA, Kreissman, SG, and Rice, HE. "Value of surgical resection in children with high-risk neuroblastoma." Pediatric blood & cancer 62, no. 9 (September 2015): 1529-1535. Full Text
  - Rice, HE, Englum, BR, Gulack, BC, Adibe, OO, Tracy, ET, Kreissman, SG, and Routh, JC. "Use of patient registries and administrative datasets for the study of pediatric cancer." Pediatric blood & cancer 62, no. 9 (September 2015): 1495-1500. (Review) Full Text
  - Bleeker, G, van Eck-Smit, BL, Zwinderman, KH, Versteeg, R, van Noesel, MM, Kam, BL, Kaspers, GJ, van Schie, A, Kreissman, SG, Yanik, G, Hero, B, Schmidt, M, Laureys, G, Lambert, B, Øra, I, Schulte, JH, Caron, HN, and Tytgat, GA. "MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis." European journal of nuclear medicine and molecular imaging 42, no. 2 (February 2015): 222-230. Full Text
  - Ladenstein, R, Boubaker, A, Lambert, B, Castellani, MR, Bar-Sever, Z, Oudoux, A, Kaminska, A, Kreissman, SG, Matthay, KK, and Poetschger, U. "SIGNIFICANT PROGNOSTIC RESULTS OF THE SIOPEN MIBG SCORING METHOD IN 2 COOPERATIVE INDEPENDENT HIGH RISK NEUROBLASTOMA TRIALS." PEDIATRIC BLOOD & CANCER 61 (December 2014): S123-S123. Link to Item
  - Landier, W, Knight, K, Wong, FL, Lee, J, Thomas, O, Kim, H, Kreissman, SG, Schmidt, ML, Chen, L, London, WB, Gurney, JG, and Bhatia, S. "Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group." J Clin Oncol 32, no. 6 (February 20, 2014): 527-534. Full Text Link to Item
  - Bleeker, G, van Eck-Smit, BL, Zwinderman, KH, Versteeg, R, van Noesel, MM, Kam, BL, Kaspers, GJ, van Schie, A, Kreissman, SG, Yanik, G, Hero, B, Schmidt, M, Laureys, G, Lambert, B, Øra, I, Schulte, JH, Caron, HN, and Tytgat, GA. "MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis." European Journal of Nuclear Medicine and Molecular Imaging 42, no. 2 (January 1, 2014): 222-230. Full Text
  - Kreissman, SG, Seeger, RC, Matthay, KK, London, WB, Sposto, R, Grupp, SA, Haas-Kogan, DA, Laquaglia, MP, Yu, AL, Diller, L, Buxton, A, Park, JR, Cohn, SL, Maris, JM, Reynolds, CP, and Villablanca, JG. "Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial." Lancet Oncol 14, no. 10 (September 2013): 999-1008. Full Text Link to Item
  - Yanik, GA, Parisi, MT, Shulkin, BL, Naranjo, A, Kreissman, SG, London, WB, Villablanca, JG, Maris, JM, Park, JR, Cohn, SL, McGrady, P, and Matthay, KK. "Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group." J Nucl Med 54, no. 4 (April 2013): 541-548. Full Text Link to Item
  - Kreissman, SG, Seeger, RC, Matthay, KK, London, WB, Sposto, R, Grupp, SA, Haas-Kogan, DA, LaQuaglia, MP, Yu, AL, Diller, L, Buxton, A, Park, JR, Cohn, SL, Maris, JM, Reynolds, CP, and Villablanca, JG. "Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): A randomised phase 3 trial." The Lancet Oncology 14, no. 10 (2013): 999-1008. Full Text
  - Bleeker, G, Caron, HN, van Eck-Smit, BLF, Versteeg, R, Kreissman, SG, Yanik, G, and Tytgat, GA. "DISTINCT METASTATIC PATTERNS IN NEUROBLASTOMA ARE CORRELATED WITH MYCN AMPLIFICATION." PEDIATRIC BLOOD & CANCER 59, no. 6 (December 2012): 1057-1058. Link to Item
  - Asgharzadeh, S, Salo, JA, Ji, L, Oberthuer, A, Fischer, M, Berthold, F, Hadjidaniel, M, Liu, CW-Y, Metelitsa, LS, Pique-Regi, R, Wakamatsu, P, Villablanca, JG, Kreissman, SG, Matthay, KK, Shimada, H, London, WB, Sposto, R, and Seeger, RC. "Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma." J Clin Oncol 30, no. 28 (October 1, 2012): 3525-3532. Full Text Link to Item
  - Shah, NR, Landi, DB, Kreissman, SG, Kulbachi, E, and Moran, C. "Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: a literature review." J Pediatr Hematol Oncol 33, no. 7 (October 2011): e316-e319. (Review) Full Text Link to Item
  - Naranjo, A, Parisi, MT, Shulkin, BL, London, WB, Matthay, KK, Kreissman, SG, and Yanik, GA. "Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group." Pediatr Blood Cancer 56, no. 7 (July 1, 2011): 1041-1045. Full Text Link to Item
  - Landier, W, Knight, KR, Wong, FL, Lee, JK, Thomas, O, Kim, H, Kreissman, SG, Schmidt, ML, Chen, L, London, WB, Bhatia, S, and Gurney, JG. "Ototoxicity in children with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales—A report from the Children's Oncology Group (COG)." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 9515-9515. Full Text
  - Landier, W, Knight, KR, Wong, FL, Lee, JK, Thomas, O, Kim, H, Kreissman, SG, Schmidt, ML, Chen, L, London, WB, Bhatia, S, and Gurney, JG. "Ototoxicity in children with high-risk neuroblastoma: Prevalence, risk factors, and concordance of grading scales-A report from the Children's Oncology Group (COG)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): 9515-.
  - Yu, AL, Gilman, AL, Ozkaynak, MF, London, WB, Kreissman, SG, Chen, HX, Smith, M, Anderson, B, Villablanca, JG, Matthay, KK, Shimada, H, Grupp, SA, Seeger, R, Reynolds, CP, Buxton, A, Reisfeld, RA, Gillies, SD, Cohn, SL, Maris, JM, Sondel, PM, and Children's Oncology Group, . "Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma." N Engl J Med 363, no. 14 (September 30, 2010): 1324-1334. Full Text Link to Item
  - Yanik, GA, Parisi, MT, Naranjo, A, Matthay, KK, London, WB, McGrady, PW, Kreissman, SG, and Shulkin, BL. "MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study." Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 9516-9516. Full Text
  - Bensimhon, P, Villablanca, JG, Sender, LS, Matthay, KK, Park, JR, Seeger, R, London, WB, Yap, JSF, and Kreissman, SG. "Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group." Pediatr Blood Cancer 54, no. 4 (April 2010): 596-602. Full Text Link to Item
  - Kreissman, SG, Villablanca, JG, Seeger, RC, Grupp, SA, London, WB, Maris, JM, Park, JR, Cohn, SL, Matthay, KK, and Reynolds, CP. "A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children's Oncology Group study." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 10011-. Link to Item
  - Kreissman, SG, Villablanca, JG, Seeger, RC, Grupp, SA, London, WB, Maris, JM, Park, JR, Cohn, SL, Matthay, KK, and Reynolds, CP. "A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children's Oncology Group study." JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008). Full Text Link to Item
  - Cornetta, K, Croop, J, Dropcho, E, Abonour, R, Kieran, MW, Kreissman, S, Reeves, L, Erickson, LC, and Williams, DA. "A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase." Cancer Gene Ther 13, no. 9 (September 2006): 886-895. Full Text Link to Item
  - Pradhan, KR, Johnson, CS, Vik, TA, Sender, LS, and Kreissman, SG. "A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support." Pediatr Blood Cancer 46, no. 7 (June 2006): 793-802. Full Text Link to Item
  - Cairo, MS, Davenport, V, Bessmertny, O, Goldman, SC, Berg, SL, Kreissman, SG, Laver, J, Shen, V, Secola, R, van de Ven, C, and Reaman, GH. "Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study." Br J Haematol 128, no. 1 (January 2005): 49-58. Full Text Link to Item
  - Hawkins, DS, Felgenhauer, J, Park, J, Kreissman, S, Thomson, B, Douglas, J, Rowley, SD, Gooley, T, Sanders, JE, and Pendergrass, TW. "Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas." Cancer 95, no. 6 (September 15, 2002): 1354-1365. Full Text Link to Item
  - Croop, JM, Cooper, R, Fernandez, C, Graves, V, Kreissman, S, Hanenberg, H, Smith, FO, and Williams, DA. "Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia." Blood 98, no. 10 (November 15, 2001): 2917-2921. Link to Item
  - Goldman, SC, Holcenberg, JS, Finklestein, JZ, Hutchinson, R, Kreissman, S, Johnson, FL, Tou, C, Harvey, E, Morris, E, and Cairo, MS. "A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis." Blood 97, no. 10 (May 15, 2001): 2998-3003. Link to Item
  - Croop, JM, Cooper, R, Seshadri, R, Fernandez, C, Graves, V, Kreissman, S, Smith, FO, Cornetta, K, Williams, DA, and Abonour, R. "Large-scale mobilization and isolation of CD34+ cells from normal donors." Bone Marrow Transplant 26, no. 12 (December 2000): 1271-1279. Full Text Link to Item
  - Wingard, JR, White, MH, Anaissie, E, Raffalli, J, Goodman, J, Arrieta, A, Albano, E, Bodensteiner, D, Broun, ER, Cagnoni, P, Greenberg, R, Hiemenz, J, Holcenberg, JS, Sepkowitz, K, Kreissman, S, Longo, WR, Roy, V, Uberti, J, Vesole, D, Buell, D, Thuma, N, Roloff, B, and Hodosh, E. "A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia." Clinical Infectious Diseases 31, no. 5 (2000): 1155-1163. Full Text
  - Asselin, BL, Kreissman, S, Coppola, DJ, Bernal, SD, Leavitt, PR, Gelber, RD, Sallan, SE, and Cohen, HJ. "Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia." J Pediatr Hematol Oncol 21, no. 1 (January 1999): 6-12. Link to Item
  - Dagher, R, Kreissman, S, Robertson, KA, Provisor, A, Bergstein, J, Burke, K, Rodman, JH, Emanuel, D, and Smith, FO. "High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor." J Pediatr Hematol Oncol 20, no. 4 (July 1998): 357-360. Link to Item
  - McCarthy, L, Smith, FO, Emanuel, D, Orazi, A, Danielson, C, Thompson, C, Thomas, C, and Kreissman, S. "Platelet depletion during pediatric peripheral blood progenitor cell (PBPC) harvesting." Transfusion Science 19, no. 1 (1998): 61--. Full Text
  - Kreissman, SG, Rackoff, W, Lee, M, and Breitfeld, PP. "High dose cyclophosphamide with carboplatin: a tolerable regimen suitable for dose intensification in children with solid tumors." J Pediatr Hematol Oncol 19, no. 4 (July 1997): 309-312. Link to Item
  - Goldman, S, Davenport, V, Reaman, G, Laver, J, Kreissman, S, Blazar, B, Berg, S, Kaye, J, Patterson, F, and Cairo, MS. "Combination of rhIL-11 + G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposdde (ICE) chemotherapy in children with solid tumors (ST): RML-11 is well tolerated at double the adult recommended dose." Experimental Hematology 25, no. 8 (1997): 786--.
  - Hinds, PS, Birenbaum, LK, Clarke-Steffen, L, Quargnenti, A, Kreissman, S, Kazak, A, Meyer, W, Mulhern, R, Pratt, C, and Wilimas, J. "Coming to terms: parents' response to a first cancer recurrence in their child." Nurs Res 45, no. 3 (May 1996): 148-153. Link to Item
  - Rackoff, WR, Gonin, R, Robinson, C, Kreissman, SG, and Breitfeld, PB. "Predicting the risk of bacteremia in childen with fever and neutropenia." J Clin Oncol 14, no. 3 (March 1996): 919-924. Full Text Link to Item
  - Kreissman, SG. "Molecular genetics: toward an understanding of childhood cancer." Semin Pediatr Surg 2, no. 1 (February 1993): 2-10. (Review) Link to Item
  - MACKLIS, RM, WEST, DC, SHAMBERGER, RC, KOZAKEWICH, HP, KREISSMAN, SG, and GRIER, HE. "LOCAL-CONTROL IN STAGE-III NEUROBLASTOMA PATIENTS OVER ONE-YEAR OF AGE - THE JOINT CENTER CHILDRENS-HOSPITAL DANA-FARBER-CANCER-INSTITUTE EXPERIENCE." INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 27 (1993): 131-132. Link to Item
  - West, DC, Shamberger, RC, Macklis, RM, Kozakewich, HP, Wayne, AS, Kreissman, SG, Korf, BR, Lavally, B, and Grier, HE. "Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents." J Clin Oncol 11, no. 1 (January 1993): 84-90. Full Text Link to Item
  - Kreissman, SG, Gelber, RD, Cohen, HJ, Clavell, LA, Leavitt, P, and Sallan, SE. "Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia." Cancer 70, no. 8 (October 15, 1992): 2208-2213. Link to Item
  - Mathey-Prevot, B, Andrews, NC, Murphy, HS, Kreissman, SG, and Nathan, DG. "Positive and negative elements regulate human interleukin 3 expression." Proc Natl Acad Sci U S A 87, no. 13 (July 1990): 5046-5050. Link to Item
  - ANDREWS, NC, MATHEYPREVOT, B, KREISSMAN, SG, and NATHAN, DG. "NUCLEAR FACTOR BINDING-SITES IN THE INTERLEUKIN (IL-3) PROMOTER." PEDIATRIC RESEARCH 27, no. 4 (April 1990): A138-A138. Link to Item
  - Vitek, MP, Kreissman, SG, and Gross, RH. "The isolation of ecdysterone inducible genes by hybridization subtraction chromatography." Nucleic Acids Res 9, no. 5 (March 11, 1981): 1191-1202. Link to Item
Teaching & Mentoring
Recent Courses
- PEDS 222C: OVERVIEW OF PEDIATRIC HEMATOLOGY-ONCOLOGY 2018
- PEDS 427C: Pediatric Hematology/Oncology 2018

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Conference Papers

Journal Articles

Recent Courses